# MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators

Study · id `cardio:ct-nct06269692` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06269692](<https://clinicaltrials.gov/study/NCT06269692>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06269692

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Heart rhythm problems; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1812 participants.

## Technical summary

Registry record NCT06269692. Randomized; no masking; primary purpose prevention. Start 2024-04-01 (anticipated); primary completion 2030-04-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1812 participants (planned count; ClinicalTrials.gov record NCT06269692, source copy `cardio:ctgov-nct06269692-2024-02-21`, retrieved 2026-10-26)
- Planned start: 2024-04-01 (anticipated) (ClinicalTrials.gov record NCT06269692, source copy `cardio:ctgov-nct06269692-2024-02-21`, retrieved 2026-10-26)
- Primary completion: 2030-04-01 (anticipated) (ClinicalTrials.gov record NCT06269692, source copy `cardio:ctgov-nct06269692-2024-02-21`, retrieved 2026-10-26)
- Completion: 2030-04-01 (anticipated) (ClinicalTrials.gov record NCT06269692, source copy `cardio:ctgov-nct06269692-2024-02-21`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT06269692, source copy `cardio:ctgov-nct06269692-2024-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06269692-2024-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators
- Acronym: SMART-DEF
- Condition: Myocardial Infarction
- Condition: Ventricular Tachycardia
- Condition: Ventricular Fibrillation
- Condition: Sudden Cardiac Death
- Intervention (Device): MRI screening
- Intervention (Device): Implantable Loop Recorder
- Intervention (Device): Implantable Cardioverter Defibrillator
- Lead sponsor: Central Hospital, Nancy, France
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Central Hospital, Nancy, France (`cardio:org-central-hospital-nancy-france`)

## Provenance

Content hash: bb2b6deba8be1a90c6ecdbb4fd9b488b02bcbbf75eeb74e883429df34b2c0061
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
